In line with this idea, promising recent work has shown that elevated PRP19 expression correlates with poorer prognosis in hepatocellular cancer (HCC) patients and that PRP19 depletion enhances the efficiency of irradiation/radiotherapy in HCC cell lines and tumor models [155]. The gene discussed is PRPF19; the disease is hepatocellular carcinoma.